AU Patent

AU2004287875B2 — Modulators of cellular adhesion

Assigned to Bausch and Lomb Ireland Ltd · Expires 2011-06-02 · 15y expired

What this patent protects

and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of dis…

USPTO Abstract

and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).

Drugs covered by this patent

Patent Metadata

Patent number
AU2004287875B2
Jurisdiction
AU
Classification
—
Expires
2011-06-02
Drug substance claim
No
Drug product claim
No
Assignee
Bausch and Lomb Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.